Methylenetetrahydrofolate reductase (MTHFR) is an essential enzyme involved in folate metabolism. MTHFR gene polymorphism (C677T), comprised of wild (CC), hetero (CT), and homo (TT) genotypes, have been implicated in several types of cancer. However, the association of MTHFR C677T polymorphism and carcinogenesis is not clear at present. This study was aimed to investigate meta-analytically which organ is the most susceptible to carcinogenesis caused by the genetic polymorphism and to clarify the association of the polymorphism and the incidence of cancer in the determined organ. Case-control and/or cohort studies describing the relation of MTHFR C677T polymorphism with cancer incidence from the PubMed database up to September, 2014 were searched to identify potentially eligible articles. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to estimate the strength of the associations. The search yielded 565 reports and among them, 61 reports on colorectal cancer met the inclusion criteria. When only the MTHFR C677T polymorphic CC type and CT type were compared for rectal cancer incidence (CT vs. CC: OR=1.10 [95% CI, 1.00-1.21], P=0.04), a significant difference was recognized. In addition, only for colorectal cancer incidence (TT vs. CC: OR=0.83 [95% CI, 0.74-0.93], P=0.001), a significant difference was recognized when comparison between the CC type and TT type was made.
View full abstract